Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [18]
In the citing paper
“Recently, we and others have shown that normal processing of the large amyloid f3 protein precursor ({3-APP) secretes 4-kDa A(3 that is readily detected in human cerebrospinal fluid and in medium conditioned by cultured cells (3)(4)(5)(6).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [3]
In the citing paper
“The demonstration that A-related peptides with the same N terminals as the CTFs documented here are present in conditioned medium of cultured cells (Seubert et al., 1992;Naslund et al., 1994;Simons et al., 1996;Wang et al., 1996;Xu et al., 1998)”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Seubert et al., 1992
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Self-citationMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa-Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,096
Cited by
Items 801–900 of 1,726
Amyloid β Peptide Formation in Cell-free Preparations
Desdouits, F., Buxbaum, J. D., Desdouits-Magnen, J., Nairn, A. C., & Greengard, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24670 · Cited by 49
Chong, Y. H., Jung, J. M., Choi, W., Park, C. W., Choi, K. S., & Suh, Y. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00853-1 · Cited by 48
Evin, G. M., Beyreuther, K. T., & Masters, C. L. (1994) · Amyloid · doi:10.3109/13506129409146118 · Cited by 60
Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease
Saido, T. C. (2013) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.89.321 · Cited by 59
Statistically quantified measurement of an Alzheimer's marker by surface‐enhanced Raman scattering
Buividas, R., Dzingelevičius, N., Kubiliūtė, R., Stoddart, P. R., Truong, V. K., Ivanova, E. P., & Juodkazis, S. (2014) · Journal of Biophotonics · doi:10.1002/jbio.201400017 · Cited by 50
Meleleo, D., Notarachille, G., Mangini, V., & Arnesano, F. (2019) · European Biophysics Journal · doi:10.1007/s00249-018-1344-9 · Cited by 49
Peng, J., Hu, Y., Zhang, H., Wan, L., Wang, L., Liang, Z., Zhang, L., & Wu, R. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00542 · Cited by 47
S655 phosphorylation enhances APP secretory traffic
Vieira, S. I., Rebelo, S., Domingues, S. C., Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0084-7 · Cited by 54
Peng, Y., Lee, D. Y. W., Jiang, L., Ma, Z., Schachter, S. C., & Lemere, C. A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.022 · Cited by 53
Behl, M., Zhang, Y., Monnot, A. D., Jiang, W., & Zheng, W. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.05.024 · Cited by 50
“Noticeably, Aβ 1–40 , a soluble form of Aβ peptides, is the major component of diffused plaques in AD patients (Mehta et al., 2000; Seubert et al., 1992; Vigo-Pelfrey et al., 1993).”
Schmidt, M. L., DiDario, A. G., Lee, V. M.-Y., & Trojanowski, J. Q. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00259-2 · Cited by 47
In vitro processing of amyloid precursor protein by cathepsin D
Sadik, G., Kaji, H., Takeda, K., Yamagata, F., Kameoka, Y., Hashimoto, K., Miyanaga, K., & Shinoda, T. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00053-9 · Cited by 51
Protection against β-Amyloid-induced Apoptosis by Peptides Interacting with β-Amyloid
Nelson, T. J., & Alkon, D. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705558200 · Cited by 50
Self-assembly of protein amyloids: A competition between amorphous and ordered aggregation
Lee, C. F. (2009) · Physical Review E · doi:10.1103/physreve.80.031922 · Cited by 50
How Fluorescent Tags Modify Oligomer Size Distributions of the Alzheimer Peptide
Wägele, J., Sio, S. D., Voigt, B., Balbach, J., & Ott, M. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.12.010 · Cited by 47
Blennow, K., & Zetterberg, H. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.07.006 · Cited by 49
Mohamadi, M. R., Svobodová, Z., Verpillot, R., Esselmann, H., Wiltfang, J., Otto, M., Taverna, M., Bílková, Z., & Viovy, J. (2010) · Analytical Chemistry · doi:10.1021/ac101337n · Cited by 50
Shen, Y., Sullivan, T., Lee, C., Meri, S., Shiosaki, K., & Lin, C. W. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00346-1 · Cited by 46
A novel substrate for analyzing Alzheimer's disease γ‐secretase
Lichtenthaler, S. F., Multhaup, G., Masters, C. L., & Beyreuther, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00730-9 · Cited by 47
Pangalos, M. N., Jacobsen, S. J., & Reinhart, P. H. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330553 · Cited by 46
Lau, T., Gehman, J. D., Wade, J. D., Perez, K. A., Masters, C. L., Barnham, K. J., & Separovic, F. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.05.004 · Cited by 46
The neurochemistry of Alzheimer's disease
Blennow, K., & Cowburn, R. F. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb00378.x · Cited by 46
Maldonado, T. A., Jones, R. E., & Norris, D. O. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02328-8 · Cited by 53
Mechanisms of synaptic pathology in Alzheimer’s disease
Masliah, E. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_13 · Cited by 51
Gandy, S., & Greengard, P. (1994) · International review of neurobiology · doi:10.1016/s0074-7742(08)60302-5 · Cited by 52
Physiological levels of β-amyloid increase tyrosine phosphorylation and cytosolic calcium
Luo, Y. Q., Hirashima, N., Li, Y. H., Alkon, D. L., Sunderland, T., Etcheberrigaray, R., & Wolozin, B. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00282-u · Cited by 46
Genetic Clues to Alzheimer's Disease
Dewji, N. N., & Singer, S. J. (1996) · Science · doi:10.1126/science.271.5246.159 · Cited by 46
Hu, Z., Wang, X., Wang, W., Zhang, Z., Gao, H., & Mao, Y. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp02366a · Cited by 49
Membrane-Mediated Peptide Conformation Change from α-Monomers to β-Aggregates
Lee, C., Sun, Y., & Huang, H. W. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.02.001 · Cited by 49
Neurochemical biomarkers in the differential diagnosis of movement disorders
Mollenhauer, B., & Trenkwalder, C. (2009) · Movement Disorders · doi:10.1002/mds.22510 · Cited by 46
“Studies in transgenic mice have shown that the lack of APP leads to impaired neuronal function.46 In 1992, Seubert et al. demonstrated the existence of extracellular Ab, including CSF.5 This observation offered new opportunities for developing diagnostic tests for AD.”
BackgroundInfluentialExplorative and targeted neuroproteomics in Alzheimer's disease
Brinkmalm, A., Portelius, E., Öhrfelt, A., Brinkmalm, G., Andréasson, U., Gobom, J., Blennow, K., & Zetterberg, H. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.01.009 · Cited by 47
Ranade, D. S., Bapat, A. M., Ramteke, S., Joshi, B. N., Roussel, P., Tomas, A., Deschamps, P., & Kulkarni, P. P. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.07.028 · Cited by 49
“We added 1% HFIP to A β(1-42) peptide monomer to induce aggregation.”
BackgroundMethodInfluentialGuinea Pigs as a Nontransgenic Model for APP Processing in Vitro and in Vivo
Beck, M., Bigl, V., & Roßner, S. (2003) · Neurochemical Research · doi:10.1023/a:1022850113083 · Cited by 49
AMYLOID β PEPTIDES STIMULATE TISSUE-TYPE PLASMINOGEN ACTIVATOR BUT NOT RECOMBINANT PROUROKINASE
Wnendt, S., Wetzels, I., & Günzler, W. A. (1997) · Thrombosis Research · doi:10.1016/s0049-3848(97)00006-6 · Cited by 45
Verpillot, R., Otto, M., Klafki, H., & Taverna, M. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.10.051 · Cited by 50
Smith, T. J., Stains, C. I., Meyer, S. C., & Ghosh, I. (2006) · Journal of the American Chemical Society · doi:10.1021/ja065557e · Cited by 45
Intracerebroventricular passive immunization with anti‐Aβ antibody in Tg2576
Chauhan, N. B., & Siegel, G. J. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10721 · Cited by 47
“Processing of APP by -, -, and -secretases occurs under normal physiological conditions, indicating that all fragments of APP including A peptides are part of normal physiology (Haass et al., 1992; Seubert et al., 1992).”
BackgroundResponse : Zinc and Alzheimer's Disease
Bush, A. I., Moir, R. D., Rosenkranz, K. M., & Tanzi, R. E. (1995) · Science · doi:10.1126/science.268.5219.1921 · Cited by 45
Shin, R. W., Bramblett, G. T., Lee, V. M., & Trojanowski, J. Q. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6825 · Cited by 45
Greenberg, B., Savage, M. J., Howland, D., Ali, S. M., Siedlak, S. L., Perry, G. L., Siman, R., & Scott, R. W. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00001-2 · Cited by 47
Boland, K., Manias, K., & Perlmutter, D. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28022 · Cited by 45
Frackowiak, J., Mazur‐Kolecka, B., Wisniewski, H. M., Potempska, A., Carroll, R. T., Emmerling, M. R., & Kim, K. S. (1995) · Brain Research · doi:10.1016/0006-8993(94)01465-t · Cited by 51
Recent Advances in the Genetics of Alzheimer's Disease
Levy‐Lahad, E., Tsuang, D. W., & Bird, T. D. (1998) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879801100202 · Cited by 50
Hormone therapy and Alzheimer?s disease: benefit or harm?
Henderson, V. W. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.2.389 · Cited by 52
“β-Amyloid can be found in the absence of AD [87], suggesting that alternative APP processing is not invariably pathological.”
BackgroundPetryniak, M. A., Wurtman, R. J., & Slack, B. E. (1996) · Biochemical Journal · doi:10.1042/bj3200957 · Cited by 45
A Review of Application of Aβ42/40 Ratio in Diagnosis and Prognosis of Alzheimer’s Disease
Xu, C., Zhao, L., & Dong, C. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220673 · Cited by 48
Single particle detection of Aβ aggregates associated with Alzheimer’s disease
Funke, S. A., Birkmann, E., Henke, F., Görtz, P., Lange‐Asschenfeldt, C., Riesner, D., & Willbold, D. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.085 · Cited by 48
Uberti, D. L., Ferrari‐Toninelli, G., Bonini, S. A., Sarnico, I., Benarese, M., Pizzi, M., Benussi, L., Ghidoni, R., Binetti, G. G., Spano, P., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301185 · Cited by 45
“Ab is a 39–43 aminoacid length peptide derived from the amyloidogenic processing of the larger amyloid precursor protein (APP) (Haas et al, 1992; Seubert et al, 1992).”
BackgroundHuman IMR‐32 neuroblastoma cells as a model cell line in Alzheimer's disease research
Neill, D., Hughes, D., Edwardson, J. A., RIMA, B. K., & Allsop, D. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390415 · Cited by 49
“The P/A4-peptide itself is now known to be a normal secreted product, several 3 and 4 kDa forms having been detected in csf and in the conditioned medium from various cell types (Haass et al., 1992; Seubert et al., 1992; Shoji et al., 1992; Busciglio et al., 1993).”
Andras, I. E., Rha, G. B., Huang, W., Eum, S. Y., Couraud, P., Romero, I. A., Hennig, B., & Toborek, M. J. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.042028 · Cited by 44
“In contrast, A (1-42) is mainly localized to the senile plaques (Seubert et al., 1992).”
BackgroundSchenk, D., Games, D., & Seubert, P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:259 · Cited by 47
“…based upon the observation that C-terminal fragments produced by β-secretase cleavage are readily apparent in cells, whereas APP fragments corresponding to a single C terminal γcleavage are not. β-peptide is constituitively secreted or released from cells (Haass et al., 1992; Seubert et al., 1992).”
BackgroundSelf-citationPavía, J., CEBALLOS, M. L. D., & de la Cuesta, F. S. (1998) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1998.tb00975.x · Cited by 52
Amaratunga, A., & Fine, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17268 · Cited by 44
Kareti, S. R., & Subash, P. (2020) · Current Therapeutic Research · doi:10.1016/j.curtheres.2020.100615 · Cited by 46
Muralidharan, P., Kumar, V., & Balamurugan, G. (2009) · Phytotherapy Research · doi:10.1002/ptr.2922 · Cited by 44
Durkin, J. T., Murthy, S., Husten, E. J., Trusko, S. P., Savage, M. J., Rotella, D. P., Greenberg, B., & Siman, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20499 · Cited by 47
β-Amyloid(25–35) induces the production of interleukin-8 from human monocytes
Meda, L., Bonaiuto, C., Szendrei, G. I., Ceska, M., Rossi, F., & Cassatella, M. A. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00021-s · Cited by 46
Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration.
Iverfeldt, K., Walaas, S. I., & Greengard, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4146 · Cited by 48
Fitzgerald, D. J. (1995) · Science · doi:10.1126/science.7604269 · Cited by 44
Balakrishnan, M., Layek, S., Balaji, S., Trivedi, V., & Iyer, P. K. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00205 · Cited by 43
Zhao, Z., Zhu, L., Bu, X., Ma, H., Yang, S., Yang, Y., & Hu, Z. (2014) · Chemical Communications · doi:10.1039/c4cc07037b · Cited by 47
Nyarko, J. N. K., Quartey, M. O., Pennington, P. R., Heistad, R. M., Dea, D., Poirier, J., Baker, G. B., & Mousseau, D. D. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.005 · Cited by 41
Adsorption of Amyloid β‐Peptide at Polymer Surfaces: A Neutron Reflectivity Study
Rocha, S., Krastev, R., Thünemann, A. F., Pereira, M. D. C., Möhwald, H., & Brezesinski, G. (2005) · ChemPhysChem · doi:10.1002/cphc.200500158 · Cited by 45
van Gool, W. A., Schenk, D. B., & Bolhuis, P. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90677-7 · Cited by 42
Self-citationTerrill-Usery, S. E., Mohan, M. J., & Nichols, M. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.08.001 · Cited by 41
“While these concentrations are higher than the low nanomolar range for normal circulating Aβ [42,43], it has been shown that total Aβ is ~100–200-fold higher in AD brain homogenates compared to controls [44].”
Gospodarska, E., Kupniewska-Kozak, A., Goch, G., & Dadlez, M. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.02.011 · Cited by 44
Controlling amyloid growth in multiple dimensions
Dong, J., Lu, K., Lakdawala, A. S., Mehta, A. K., & Lynn, D. G. (2006) · Amyloid · doi:10.1080/13506120600960809 · Cited by 42
“Although the pathological role of Ab is unclear, this soluble peptide is present in all individuals at picomolar concentrations [ 13 ,14], and the transition from soluble Ab to a non-native conformation capable of aggregation into fibrils appears intimately associated with disease progression [15].”
BackgroundTiiman, A., Jarvet, J., Gräslund, A., & Vukojević, V. B. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00976 · Cited by 42
He, B., Xu, F., Yan, T., Xiao, F., Wu, B., Wang, Y., Bi, K., & Jia, Y. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.11.002 · Cited by 41
ALZHEIMER'S SOLUBLE AMYLOID BETA PROTEIN IS SECRETED BY HEPG2 CELLS AS AN APOLIPOPROTEIN
KOUDINOV, A. R., & KOUDINOVA, N. V. (1997) · Cell Biology International · doi:10.1006/cbir.1996.0126 · Cited by 41
Kunicki, S., Richardson, J., Mehta, P. D., Kim, K. S., & Zorychta, E. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00027-7 · Cited by 47
The βA4 Amyloid Precursor Protein Gene and Alzheimer's Disease
Hendriks, L., & Broeckhoven, C. V. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0006n.x · Cited by 44
Formation of Toxic Amyloid Fibrils by Amyloid β‐Protein on Ganglioside Clusters
Matsuzaki, K. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/956104 · Cited by 40
“The physiological concentration of Aβ in biological fluids (<10−8 M) [4] is much lower than the concentration (∼ 1 μM) above which Aβ-(1–40) spontaneously forms fibrils [5].”
BackgroundAn Azobenzene Photoswitch Sheds Light on Turn Nucleation in Amyloid-β Self-Assembly
Doran, T. M., Anderson, E. A., Latchney, S. E., Opanashuk, L. A., & Nilsson, B. L. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn2001188 · Cited by 42
Molecular Aspects of Inflammatory and Immune Responses in Alzheimer's Disease
Kalaria, R. N., Harshbarger-Kelly, M., Cohen, D., & Premkumar, D. R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00114-5 · Cited by 40
β-Amyloid Peptide Produced in Vitro Is Degraded by Proteinases Released by Cultured Cells
Naidu, A., Quon, D., & Cordell, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1369 · Cited by 41
Colón, W., Lai, Z., McCutchen, S. L., Miroy, G. J., Strang, C. J., & Kelly, J. W. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514924.ch14 · Cited by 40
Lannfelt, L., Basun, H., Vigo-Pelfrey, C., Wahlund, L.-O., Winblad, B., Lieberburg, I., & Schenk, D. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12059-d · Cited by 39
Self-citationAndr�s, M. E., Gysling, K., Araneda, S., Venegas, A., & Bustos, G. A. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19961101)46:3<294::aid-jnr2>3.0.co;2-f · Cited by 22
Fagiani, F., Lanni, C., Racchi, M., & Govoni, S. M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.635880 · Cited by 44
Macromolecules involved in production and metabolism of beta-amyl oid at the brain barriers
Crossgrove, J. S., Smith, E. L., & Zheng, W. (2007) · Brain Research · doi:10.1016/j.brainres.2006.12.022 · Cited by 42
“…fluids of the brain, including the cerebrospinal fluid (CSF) supporting the brain and circulating in brain ventricles, and the interstitial fluid surrounding the neurons and glial cells in brain lobes (Price et al., 1998; Selkoe, 2001; Seubert et al., 1992; Vigo-Pelfrey et al., 1993).”
BackgroundInfluentialMoghekar, A., Rao, S. B., Li, M., Ruben, D. S., Mammen, A. L., Tang, X., & O’Brien, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.191262 · Cited by 50
Morphological Development of β(1-40) Amyloid Fibrils
Blackley, H. K. L., Patel, N., Davies, M. C., Roberts, C. J., Tendler, S. J. B., Wilkinson, M. J., & Williams, P. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7114 · Cited by 40
Rapid Assembly of Amyloid-β Peptide at a Liquid/Liquid Interface Produces Unstable β-Sheet Fibers
Nichols, M. R., Moss, M. A., Reed, D. K., Hoh, J. H., & Rosenberry, T. L. (2004) · Biochemistry · doi:10.1021/bi048846t · Cited by 43
Cellular Cofactors for Amyloid β-Peptide-Induced Cell Stress
Yan, S. D., Roher, A., Schmidt, A. M., & Stern, D. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65452-1 · Cited by 39
γ-Secretase Cleavage Site Specificity Differs for Intracellular and Secretory Amyloid β
Grimm, H. S., Beher, D., Lichtenthaler, S. F., Shearman, M. S., Beyreuther, K., & Hartmann, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210380200 · Cited by 41
Vandermeeren, M., Geraerts, M., Pype, S., Dillen, L., Hove, C. V., & Mercken, M. H. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02369-2 · Cited by 42
Membrane destabilization induced by β-amyloid peptide 29-42: Importance of the amino-terminus
Mingeot‐Leclercq, M., Lins, L., Bensliman, M., Françoise Van Bambeke, A., Smissen, P. V. D., Peuvot, J., Schanck, A. N., & Brasseur, R. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00108-1 · Cited by 39
Kontush, A., Donarski, N., & Beisiegel, U. (2001) · Free Radical Research · doi:10.1080/10715760100301521 · Cited by 39
Coughlan, C. M., & Breen, K. C. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00036-x · Cited by 44
Li, X., Uemura, K., Hashimoto, T., Nasser-Ghodsi, N., Arimon, M., Lill, C. M., Palazzolo, I., Krainc, D., Hyman, B. T., & Berezovska, O. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.002 · Cited by 38
“The normal physiological concentration of Aβ in human cerebrospinal fluid and plasma of non-demented subjects (Giedraitis et al., 2007; Seubert et al., 1992; Shoji and Kanai, 2001) or in wild type rodent brains (Kawarabayashi et al.”
Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines
Mandler, M., Santic, R., Gruber, P., Cinar, Y., Pichler, D., Funke, S. A., Willbold, D., Schneeberger, A., SCHMIDT, W. A., & Mattner, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115237 · Cited by 40
Portelius, E., Dean, R. A., Andreasson, U., Mattsson, N., Westerlund, A., Olsson, M., Demattos, R. B., Racke, M. M., Zetterberg, H., May, P. C., et al. (2014) · Alzheimer's Research & Therapy · doi:10.1186/s13195-014-0075-0 · Cited by 38
“For quantification of Aβ5-40 and Aβ5-x using ELISA, microtiter plates were coated with 10 μg/mL 2G3 [21] (anti-Aβx-40; epitope including valine at position 40, Eli Lilly & Company, Indianapolis, IN, USA) or 266 [22] (anti-Aβ1-x; epitope 13-28, Eli Lilly & Company) overnight at 4°C.”
MethodHeme and hemoglobin suppress amyloid β–mediated inflammatory activation of mouse astrocytes
Sankar, S. B., Donegan, R. K., Shah, K. J., Reddi, A. R., & Wood, L. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001050 · Cited by 38
“Since physiologic concentrations of Aβ1-42 are reported to be in the sub-low nM range (31-34), we used 50nM Aβ1-42 for all culture conditions.”
MethodHossain, S., Hashimoto, M., Katakura, M., Al Mamun, A., & Shido, O. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0620-9 · Cited by 38
“Aβ1–40 prevails in the cerebrospinal fluid of patients with AD [2].”
BackgroundIslam, K., & Levy, E. (1997) · Europe PMC (PubMed Central) · Cited by 40
Alzheimer's amyloid beta and lipid metabolism: a missing link?
Koudinov, A. R., Berezov, T. T., & Koudinova, N. V. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1097 · Cited by 38
Monogenetic determinants of Alzheimer's disease: APP mutations
Goate, A. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050218 · Cited by 43
Mattson, M. P., Furukawa, K., Bruce‐Keller, A. J., Mark, R. J., & Blanc, E. M. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_8 · Cited by 41
Kim, D.-K., Park, J., & Choi, B. (2014) · The Journal of Toxicological Sciences · doi:10.2131/jts.39.625 · Cited by 38
“In particular, Aβ1-42 has a high propensity for aggregation and fibrillogenesis and is a common component of plaques (Prelli et al., 1988; Seubert et al., 1992; Donnelly et al., 2007).”
Background
Metadata
- Authors
- Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., & Schenk, D.
- Affiliations
- Austrian Academy of Sciences (AT)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6393
- Pages
- 325-327
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086278983
- Cited by
- 1,731
- References
- 28
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 32 · 2023: 19 · 2022: 22 · 2021: 31 · 2020: 28 · 2019: 25 · 2018: 35 · 2017: 39 · 2016: 31 · 2015: 48 · 2014: 46 · 2013: 39 · 2012: 50
- FWCI
- 72.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, cerebrospinal fluid, plasma, conditioned medium, sandwich ELISA, affinity chromatography, epitope-specific antibodies, amyloid deposition, diagnostic biomarkers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Antibodies, Monoclonal, Brain, Cells, Cultured, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Humans, Molecular Sequence Data, Peptide Fragments, Radioimmunoassay, Solubility, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.